Effects of glycosaminoglycans on proliferation of epithelial and fibroblast human malignant mesothelioma cells: a structure–function relationship

Abstract. Proteoglycans interact with other effective macromolecules regulating a variety of cellular events via their glycosaminoglycan (GAG) chains. The effects of all known glycosaminoglycans (GAGs) produced by normal cells and tissues on the proliferation of two human malignant mesothelioma cell lines, one with fibroblast‐like morphology and the other with epithelial differentiation – both able to produce hyaluronan (HA), galactosaminoglycans (GalAGs) and heparan sulphate (HS) containing proteoglycans – have been studied. Cell proliferation was assessed by measuring [3H]thymidine incorporation and cell number. GalAGs, i.e. chondroitin sulphates (CSs) and dermatan sulphate (DS), strongly stimulate the proliferation of fibroblast‐like cells in a dose‐dependent manner (170–250% at 100 μg/ml), independently of their sulphation pattern. In epithelial cells, however, only DS stimulates cell proliferation. The effects of CSs on proliferation of epithelial cells are not depended on their sulphation pattern. Thus, CSs either with ‐[GlcA‐GalNAc‐(‐6‐O‐SO3−)]‐ or ‐[GlcA‐GalNAc‐(‐4‐O‐SO3−]‐ as the commonest unit, had no significant effect. l‐Iduronic acid (IdoA)‐rich heparin and fast‐moving HS (fm‐HS), a HS fraction with a heparin‐like structure, had significant antiproliferative effects on mesothelioma cells of both types (30–70% at 1.0 μg/ml and 85–90% at 100 μg/ml, respectively). GlcA‐rich HS, however, had no significant effects. HA inhibits only the proliferation of fibroblast‐like cells by 25% at 50 and 100 μg/ml. Keratan sulphate suppresses cell proliferation (10–30%) in both cell lines. In the view of these findings, a structure–function relationship of GAGs on cell proliferation of the two human malignant mesothelioma cell lines is discussed. Other factors, such as chain conformation and geometry, as well as interactions of growth factors with GAGs, possibly involved in the regulation of cell proliferation, are also discussed.

[1]  A. Hjerpe,et al.  High-performance capillary electrophoretic analysis of hyaluronan in effusions from human malignant mesothelioma. , 1997, Journal of chromatography. B, Biomedical sciences and applications.

[2]  N. Karamanos,et al.  Proteoglycan synthesis induced by transforming and basic fibroblast growth factors in human malignant mesothelioma is mediated through specific receptors and the tyrosine kinase intracellular pathway. , 1997, Biochimie.

[3]  N. Karamanos,et al.  Ion-pair high-performance liquid chromatography for determining disaccharide composition in heparin and heparan sulphate. , 1997, Journal of chromatography. A.

[4]  A. Hjerpe,et al.  Effect of insulin and epidermal growth factors on the synthesis of glycosaminoglycans/proteoglycans in cultured human malignant mesothelioma cells of different phenotypic morphology , 1996, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[5]  T. Laurent,et al.  Serum hyaluronan as a disease marker. , 1996, Annals of medicine.

[6]  A. Hjerpe,et al.  High performance capillary electrophoresis method to characterize heparin and heparan sulfate disaccharides , 1996, Electrophoresis.

[7]  A. Hjerpe,et al.  Effects on glycosaminoglycan synthesis in cultured human mesothelioma cells of transforming, epidermal, and fibroblast growth factors and their combinations with platelet-derived growth factor. , 1995, Experimental cell research.

[8]  N. Karamanos,et al.  Determination of hyaluronan and galactosaminoglycan disaccharides by high-performance capillary electrophoresis at the attomole level. Applications to analyses of tissue and cell culture proteoglycans. , 1995, Journal of chromatography. A.

[9]  N. Karamanos,et al.  Glycosaminoglycans from two human malignant mesothelioma cell lines: determination, distribution, and effect of platelet-derived growth factor on their synthesis. , 1995, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[10]  A. Conte,et al.  Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: structure-function relationship. , 1994, Experimental cell research.

[11]  N. Karamanos,et al.  Determination of 24 variously sulfated galactosaminoglycan- and hyaluronan-derived disaccharides by high-performance liquid chromatography. , 1994, Analytical biochemistry.

[12]  P. Heldin,et al.  Hyaluronan receptors are expressed on human malignant mesothelioma cells but not on normal mesothelial cells. , 1994, Cancer research.

[13]  A. Hjerpe,et al.  Clinical utility of liquid-chromatographic analysis of effusions for hyaluronate content. , 1994, Clinical chemistry.

[14]  J. Scott On the polylactose nature of chondroitin and keratan sulphates. , 1994, The Biochemical journal.

[15]  G. Dimitracopoulos,et al.  Isolation and characterization of a novel 20-kDa sulfated polysaccharide from the extracellular slime layer of Staphylococcus epidermidis. , 1994, Archives of biochemistry and biophysics.

[16]  A. Conte,et al.  Effects of chondroitin sulfates with different structures on leukemia cells: U-937 cell proliferation and differentiation. , 1993, Leukemia research.

[17]  G. David Integral membrane heparan sulfate proteoglycans , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  A. Isaksson,et al.  L-iduronate-rich glycosaminoglycans inhibit growth of normal fibroblasts independently of serum or added growth factors. , 1993, Experimental cell research.

[19]  F M Watt,et al.  Regulation of development and differentiation by the extracellular matrix. , 1993, Development.

[20]  E. Qwarnstrom,et al.  The role of proteoglycans in cell adhesion, migration and proliferation. , 1992 .

[21]  M. Petitou,et al.  Chemical synthesis of glycosaminoglycans: new approaches to antithrombotic drugs. , 1991, Nature.

[22]  R L Jackson,et al.  Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. , 1991, Physiological reviews.

[23]  Jeffrey D. Esko,et al.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor , 1991, Cell.

[24]  L. Kjellén,et al.  Proteoglycans: structures and interactions. , 1991, Annual review of biochemistry.

[25]  G. Gahrton,et al.  Serum-dependent growth patterns of two, newly established human mesothelioma cell lines. , 1989, Cancer research.

[26]  C. Heldin,et al.  Growth factors as transforming proteins. , 1989, European journal of biochemistry.

[27]  M. Karnovsky,et al.  Structural determinants of heparin's growth inhibitory activity. Interdependence of oligosaccharide size and charge. , 1989, The Journal of biological chemistry.

[28]  A. Hjerpe,et al.  Determination of iduronic acid and glucuronic acid in glycosaminoglycans after stoichiometric reduction and depolymerization using high-performance liquid chromatography and ultraviolet detection. , 1988, Analytical biochemistry.

[29]  D. Rifkin,et al.  Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation , 1988, The Journal of cell biology.

[30]  M. Karnovsky,et al.  Metabolic effects of heparin on rat cervical epithelial cells , 1987, Journal of cellular physiology.

[31]  M. Bernfield,et al.  Heparin inhibits proliferation of fetal vascular smooth muscle cells in the absence of platelet‐derived growth factor , 1986, Journal of cellular physiology.

[32]  P. Harper,et al.  Heparin and glomerular epithelial cell-secreted heparin-like species inhibit mesangial-cell proliferation. , 1985, The American journal of pathology.

[33]  B. Caleb,et al.  Binding and internalization of heparin by vascular smooth muscle cells , 1985, Journal of cellular physiology.

[34]  R. Rosenberg,et al.  An antiproliferative heparan sulfate species produced by postconfluent smooth muscle cells , 1985, The Journal of cell biology.

[35]  F. Reinholt,et al.  MORPHOLOGICAL AND BIOCHEMICAL ANALYSIS OF BIOPSY SPECIMENS IN DISORDERS OF SKELETAL DEVELOPMENT , 1982, Acta paediatrica Scandinavica.

[36]  R. Rosenberg,et al.  Cultured endothelial cells produce heparinlike inhibitor of smooth muscle cell growth , 1981, The Journal of cell biology.

[37]  J. Shively,et al.  Formation of anhydrosugars in the chemical depolymerization of heparin. , 1976, Biochemistry.

[38]  R. Hata,et al.  A rapid and micro method for separation of acidic glycosaminoglycans by two-dimensional electrophoresis. , 1972, Analytical biochemistry.

[39]  P. Kraemer Heparan sulfates of cultured cells. I. Membrane-associated and cell-sap species in Chinese hamster cells. , 1971, Biochemistry.

[40]  T. Kinoshita,et al.  Analytical chemical studies on amino sugars. II. Determination of hexosamines using 3-methyl-2-benzothiazolone hydrazone hydrochloride. , 1969, Chemical & pharmaceutical bulletin.